What is Docquity?
Docquity operates as a specialized digital ecosystem designed to facilitate continual learning and professional networking for doctors across Southeast Asia. The platform serves as a secure, verified environment where medical experts can engage in clinical discussions, access interactive educational content, and earn Continuing Medical Education (CME) or Continuing Professional Development (CPD) credits. By addressing the critical need for reliable, peer-reviewed information in a digital-first format, Docquity has established itself as an essential utility for modern healthcare providers. The company's market position is defined by its commitment to privacy, security, and the democratization of medical knowledge, effectively bridging the gap between traditional clinical practice and modern digital health solutions.
How much funding has Docquity raised?
Docquity has raised a total of $55M across 2 funding rounds:
Series B
$11M
Series C
$44M
Series B (2019): $11M with participation from Itochu Corporation, KDV Holdings, Jo Hirao, and SPH Ventures
Series C (2022): $44M led by ITOCHU, Alkemi, iGlobe Partners, KDV, Infocom, and Global Brain
Key Investors in Docquity
ITOCHU
ITOCHU is a leading Japanese trading corporation with a diverse portfolio spanning energy, technology, and finance, providing strategic business investment and global operational expertise.
iGlobe Partners
iGlobe Partners is a Singapore-based venture capital firm that specializes in nurturing startups into global leaders, with a strong track record in the technology and healthcare sectors.
Global Brain
Global Brain is an independent venture capital firm that provides hands-on assistance and strategic consulting to startups, leveraging a vast network to foster innovation in healthcare and technology.
What's next for Docquity?
Looking ahead, the infusion of capital from this major strategic investment will likely be directed toward accelerating product innovation and regional market penetration. As Docquity transitions into its next phase of maturity, the focus will shift toward enhancing the platform's clinical decision-support tools and expanding its footprint into emerging healthcare markets. The company is expected to leverage its existing partnerships with global institutional investors to refine its business model, potentially exploring new revenue streams through data-driven insights and expanded enterprise services. By maintaining its focus on high-quality, verified content, Docquity is poised to remain a cornerstone of the digital health infrastructure in Southeast Asia, driving long-term value for both its users and its stakeholders.
See full Docquity company page
